Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Learn how to utilize no fee Visa cards for your financial advantage. Enhance your savings strategy now!
19,308 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A sharp increase in crypto phishing is targeting developers on GitHub. Attackers lure openclaw developers lured githu...
The S&P 500 enters perpetual trading on Hyperliquid, a historic move that opens nonstop access to the U.S. benchm...
A private AI startup is offering a sub-$1 pre-IPO round open to retail investors, pricing shares at $0.66 and promisi...
Thinking about should lockheed martin stock? This practical guide breaks down the defense giant’s outlook, key cataly...
Oil shocks aren’t just headlines. This guide breaks down five real ways a $100 oil price affects your wallet and your...
Kalshi locks billion valuation as a $1B round led by Coatue pushes the U.S. prediction market leader to a $22B valuat...
Three durable businesses stand out for a buy-and-hold approach as markets adjust to AI-driven demand and steadier gro...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...
Rising housing costs strain households and the broader economy. Smart tax policy can lower those costs by acceleratin...
AI is nearing a dramatic turning point. Wedbush predicts a 2026 inflection, and this article explains what that means...
Target’s dividend king status remains intact for now, but a cash flow squeeze and higher capex raise questions for in...